Inspire Medical Systems Profit Margin 2017-2023 | INSP

Current and historical gross margin, operating margin and net profit margin for Inspire Medical Systems (INSP) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Inspire Medical Systems net profit margin as of December 31, 2023 is -3.39%.
Inspire Medical Systems Annual Profit Margins
Inspire Medical Systems Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Information Systems $6.715B $0.625B
Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $39.189B 21.80
10x Genomics (TXG) United States $3.670B 0.00
Axonics (AXNX) United States $3.435B 0.00
IRhythm Technologies (IRTC) United States $3.419B 0.00
Enovis (ENOV) United States $3.098B 23.54
Azenta (AZTA) United States $2.910B 237.18
Olink Holding AB (publ) (OLK) Sweden $2.818B 0.00
Hims & Hers Health (HIMS) United States $2.719B 0.00
Privia Health (PRVA) United States $2.099B 93.11
Schrodinger (SDGR) United States $1.790B 0.00
Phreesia (PHR) United States $1.297B 0.00
Omnicell (OMCL) United States $1.224B 29.94
Definitive Healthcare (DH) United States $0.861B 0.00
Standard BioTools (LAB) United States $0.786B 0.00
Fulgent Genetics (FLGT) United States $0.620B 0.00
Talkspace (TALK) United States $0.512B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.325B 0.00
Health Catalyst (HCAT) United States $0.324B 0.00
Clover Health Investments (CLOV) United States $0.310B 0.00
Pulmonx (LUNG) United States $0.286B 0.00
Butterfly Network (BFLY) United States $0.187B 0.00
Augmedix (AUGX) United States $0.168B 0.00
P3 Health Partners (PIII) United States $0.149B 0.00
American Well (AMWL) United States $0.149B 0.00
MSP Recovery (LIFW) United States $0.129B 0.00
TruBridge (TBRG) United States $0.122B 5.22
Outset Medical (OM) United States $0.108B 0.00
111 (YI) China $0.084B 0.00
Future Health ESG (FHLT) United States $0.076B 0.00
SHL Telemedicine (SHLT) Israel $0.074B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
HeartBeam (BEAT) United States $0.047B 0.00
EUDA Health Holdings (EUDA) Singapore $0.045B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.034B 0.00
Movano (MOVE) United States $0.026B 0.00
Cue Health (HLTH) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
ETAO (ETAO) United States $0.019B 0.00
CareCloud (CCLD) United States $0.019B 0.00
Akili (AKLI) United States $0.018B 0.00
Strata Skin Sciences (SSKN) United States $0.017B 0.00
Centogene (CNTG) Germany $0.013B 0.00
Biotricity (BTCY) United States $0.011B 0.00
Transgenomic (PRPO) United States $0.010B 0.00
Syra Health (SYRA) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00